Anthracyclines and Early Breast Cancer: The End of an Era?

被引：16
作者：
Gianni, Luca [1 ,2 ]
机构：
[1] Ist Tumori Milano, Div Med Oncol, Milan, Italy
[2] Fdn Michelangelo, Milan, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 08期
关键词：
ADJUVANT CHEMOTHERAPY; RANDOMIZED-TRIAL; FOLLOW-UP; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; EPIRUBICIN; DOCETAXEL; METHOTREXATE; PACLITAXEL;
D O I：
10.1200/JCO.2008.20.1640
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1155 / 1157
页数：3
相关论文
共 50 条
  • [41] Gene expression profile predicts outcome after anthracycline-based adjuvant chemotherapy in early breast cancer
    Bertucci, Francois
    Borie, Nathalie
    Roche, Henri
    Bachelot, Thomas
    Le Doussal, Jean-Marc
    Macgrogan, Gaetan
    Debono, Stephane
    Martinec, Agnes
    Treilleux, Isabelle
    Finetti, Pascal
    Esterni, Benjamin
    Extra, Jean-Marc
    Geneve, Jean
    Hermitte, Fabienne
    Chabannon, Christian
    Jacquemier, Jocelyne
    Martin, Anne-Laure
    Longy, Michel
    Maraninchi, Dominique
    Fert, Vincent
    Birnbaum, Daniel
    Viens, Patrice
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 127 (02) : 363 - 373
  • [42] Benefit from anthracyclines in relation to biological profiles in early breast cancer
    Rocca, Andrea
    Bravaccini, Sara
    Scarpi, Emanuela
    Mangia, Anita
    Petroni, Stella
    Puccetti, Maurizio
    Medri, Laura
    Serra, Luigi
    Ricci, Monica
    Cerasoli, Serenella
    Biglia, Nicoletta
    Maltoni, Roberta
    Giunchi, Donata Casadei
    Gianni, Lorenzo
    Tienghi, Amelia
    Brandi, Mario
    Faedi, Monica
    Sismondi, Piero
    Paradiso, Angelo
    Silvestrini, Rosella
    Amadori, Dino
    BREAST CANCER RESEARCH AND TREATMENT, 2014, 144 (02) : 307 - 318
  • [43] Prolonged Disease Control after Myeloablative Chemotherapy, Autologous Transplantation and Immunotherapy in High-risk Early Breast Cancer
    Recchia, Francesco
    Candeloro, Giampiero
    Necozione, Stefano
    Accorsi, Patrizia
    Recchia, Cornelia Ortensia Carla
    Tombolini, Vincenzo
    Rea, Silvio
    ANTICANCER RESEARCH, 2010, 30 (01) : 209 - 215
  • [44] Dose-dense chemotherapy versus conventional chemotherapy for early breast cancer: A systematic review with meta-analysis
    Duarte, Igor Lemos
    da Silveira Nogueira Lima, Joao Paulo
    Passos Lima, Carmen Silvia
    Sasse, Andre Deeke
    BREAST, 2012, 21 (03) : 343 - 349
  • [45] Evaluation of Therapeutic Efficacy and Health Related Quality of Life of Anthracyclines Regimen and Taxanes with Anthracyclines Regimen in Node Positive Breast Cancer
    Sivasankaran, Ponnusankar
    Mohan, Anjana
    JOURNAL OF YOUNG PHARMACISTS, 2019, 11 (02) : 177 - 181
  • [46] Neoadjuvant Chemotherapy of Taxanes With or Without Anthracyclines in Different Molecular Subtypes of Breast Cancer: A Propensity Score Matching Study
    Xiao, Jingjing
    Wang, Ting
    Yi, Jun
    Huang, Meiling
    Yan, Changjiao
    Ling, Rui
    CLINICAL BREAST CANCER, 2023, 23 (08) : 882 - 893
  • [47] Evolution of adjuvant chemotherapy for breast cancer
    von Minckwitz, Gunter
    Loibl, Sibylle
    LANCET, 2015, 385 (9980) : 1812 - 1814
  • [48] Systemic therapy for early breast cancer in older adults: current status and prospects
    Battisti, Nicolo Matteo Luca
    Biganzoli, Laura
    CURRENT OPINION IN ONCOLOGY, 2021, 33 (06) : 574 - 583
  • [49] Trastuzumab containing regimens for early breast cancer
    Moja, Lorenzo
    Tagliabue, Ludovica
    Balduzzi, Sara
    Parmelli, Elena
    Pistotti, Vanna
    Guarneri, Valentina
    D'Amico, Roberto
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (04):
  • [50] Optimizing the use of anthracyclines in older patients with breast cancer
    Morris, Patrick G.
    Fornier, Monica N.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2011, 77 (02) : 131 - 141
12345